Ontology highlight
ABSTRACT:
SUBMITTER: Prive BM
PROVIDER: S-EPMC7490874 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
Privé Bastiaan M BM Janssen Marcel J R MJR van Oort Inge M IM Muselaers Constantijn H J CHJ Jonker Marianne A MA de Groot Michel M Mehra Niven N Verzijlbergen J Fred JF Scheenen Tom W J TWJ Zámecnik Patrik P Barentsz Jelle O JO Gotthardt Martin M Noordzij Walter W Vogel Wouter V WV Bergman Andries M AM van der Poel Henk G HG Vis André N AN Oprea-Lager Daniela E DE Gerritsen Winald R WR Witjes J Alfred JA Nagarajah James J
BMC cancer 20200914 1
<h4>Background</h4>In recent years, there is increasing evidence showing a beneficial outcome (e.g. progression free survival; PFS) after metastases-directed therapy (MDT) with external beam radiotherapy (EBRT) or targeted surgery for oligometastatic hormone sensitive prostate cancer (oHSPC). However, many patients do not qualify for these treatments due to prior interventions or tumor location. Such oligometastatic patients could benefit from radioligand therapy (RLT) with <sup>177</sup>Lu-PSMA ...[more]